Last reviewed · How we verify

NCT03283748: DMS-WBAN

Detection of Motor Seizures Using WBAN

Completed NA Last updated 24 February 2021
What this trial tests

NA trial testing Wearable sensors in Seizures, Tonic-Clonic in 5 participants. Completed in 30 January 2019.

Timeline
1 November 2017
Primary endpoint
25 February 2018
30 January 2019

Quick facts

Lead sponsorMohawk College
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment5
Start date1 November 2017
Primary completion25 February 2018
Estimated completion30 January 2019
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Mohawk College

Who can join

18 and older, any sex, with Seizures, Tonic-Clonic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to collect the motor movement data using sensors to detect Generalized Tonic Clonic Seizures . Wearable sensors similar to smart watches will be used to detect seizures. The proposed system will consist of 3-4 wearable wireless sensor worn on the hands and legs. The data from these sensors will be send to the clod and collected to a central hub for analysis and detection of GTC Seizures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03283748.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing